ERBB2 and gastric cancer: In this case study, we present a patient with HER-2-negative, PD-L1 negative, mismatch repair proficient (pMMR) metastatic gastric cancer, who has achieved a durable complete response, following treatment with capecitabine and oxaliplatin (CAPOX) with platinum doublet chemotherapy.